Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MOS | Ann: Ceasing to be a substantial holder | 25/10/10 | 0 | 1.4K | |||
|
|||||||
MOS | Ann: Ceasing to be a substantial holder | 22/10/10 | 0 | 831 | |||
|
|||||||
MOS | Ann: Removal from Official List (close of trading | 21/10/10 | 0 | 889 | |||
|
|||||||
AGK +MOS | Ann: Mosaic Implements Scheme | 20/10/10 | 0 | 915 | |||
|
|||||||
AGK +MOS | Ann: Implementation of the Mosaic Oil Scheme of A | 20/10/10 | 0 | 1.1K | |||
|
|||||||
MOS | pink slipped | 14/10/10 | 7 | 3.8K | |||
|
|||||||
MOS | what happens now | 13/10/10 | 0 | 895 | |||
|
|||||||
MOS | Ann: Change in substantial holding | 13/10/10 | 0 | 571 | |||
|
See All Discussions